Opendata, web and dolomites

SAFE-N-MEDTECH SIGNED

SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "SAFE-N-MEDTECH" data sheet

The following table provides information about the project.

Coordinator
TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL 

Organization address
address: AREA INDUSTRIAL PERGUITA C/A 1
city: LOS ARCOS
postcode: 31210
website: http://www.tecnan-nanomat.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 18˙344˙674 €
 EC max contribution 14˙534˙365 € (79%)
 Programme 1. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-NMBP-HUBS-2018
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2023-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECNOLOGIA NAVARRA DE NANOPRODUCTOS SL ES (LOS ARCOS) coordinator 350˙398.00
2    BIOKERALTY RESEARCH INSTITUTE AIE ES (ARCAUTE ALAVA) participant 1˙826˙750.00
3    CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. ES (MADRID) participant 968˙657.00
4    TECHNISCHE UNIVERSITEIT EINDHOVEN NL (EINDHOVEN) participant 853˙000.00
5    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 801˙885.00
6    SINTEF AS NO (TRONDHEIM) participant 799˙037.00
7    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 732˙500.00
8    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) participant 714˙815.00
9    LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA PT (BRAGA) participant 669˙625.00
10    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 633˙517.00
11    STATENS ARBEIDSMILJOINSTITUTT NO (OSLO) participant 615˙000.00
12    STRYKER TRAUMA GMBH DE (SCHONKIRCHEN) participant 556˙087.00
13    FUNDACION TECNALIA RESEARCH & INNOVATION ES (DERIO BIZKAIA) participant 555˙643.00
14    GREENDECISION SRL IT (VENEZIA) participant 553˙875.00
15    VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V. BE (MOL) participant 512˙500.00
16    COUNCIL OF EUROPEAN BIOREGIONS BE (BRUXELLES) participant 496˙250.00
17    UNIVERSITA DEGLI STUDI DI PAVIA IT (PAVIA) participant 487˙500.00
18    RESONANT CIRCUITS LIMITED UK (LONDON) participant 464˙194.00
19    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR (PARIS) participant 430˙250.00
20    MARACA INTERNATIONAL BE (ROTSELAAR) participant 413˙000.00
21    INSTITUTUL DE CHIMIE FIZICA ILIE MURGULESCU RO (BUCHAREST) participant 324˙250.00
22    DEPARTAMENTO DE SALUD GOBIERNO VASCO ES (VITORIA-GASTEIZ) participant 306˙880.00
23    KERALTY SAS CO (BOGOTA) participant 297˙500.00
24    EUROSCAN INTERNATIONAL NETWORK EV DE (KOLN) participant 171˙250.00
25    CHINA PHARMACEUTICAL UNIVERSITY CN (NANJING) participant 0.00
26    HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD CN (EZHOU) participant 0.00
27    NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY, CHINA CN (BEIJING) participant 0.00
28    STRYKER TRAUMA GMBH DE (SCHONKIRCHEN) participant 0.00

Map

 Project objective

Society and clinical practice pose a growing demand on novel biomaterials, ICT, micro and nanotechnologies for innovative medical devices and in vitro diagnostics (Medical Technologies-MTs). In addition to the challenge of time, the new technologies are subjected to other pressing factors such as qualification, regulation, cost, biocompatibility and the need to be applicable worldwide. In the most recent years it is obvious that nano-enabled MTs can be applied in nearly every medical area, with a major presence and increased importance in cancer, regenerative medicine, advanced therapies, neurology, cardiology, orthopaedics, and dentistry. On the other hand, any innovation in the Health sector has to be carefully assessed in terms of risk/benefit ratio. Nano-enabled MTs particularly require careful assessment, since they are complex products group and their technological assessments are still under development. This assessment will be a key pillar for the here proposed Open Innovation Test Bed (OITB) To address all the aforementioned challenges, the SAFE-N-MEDTECH consortium aims to bring a strong and competitive cooperation to compete in the market for a coordinated OITB for nano-enabled MTs. SAFE-N-MEDTECH will build an innovative open access platform to offer to companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices. This across the whole Life Cycle. This OITB will offer a multidisciplinary and market oriented innovation approach to SME´s, Healthcare providers and Industries for the translation to the market of MTs, based on a deep understanding and knowledge of the material-nanoproperties, their advance use and applications in MTs and other aspects involved in MTs safety (electric compatibility, electromagnetic properties, etc).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAFE-N-MEDTECH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAFE-N-MEDTECH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.3.;H2020-EU.2.1.2.)

MEFISTO (2019)

MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy

Read More  

Repair3D (2019)

Recycling and Repurposing of Plastic Waste for Advanced 3D Printing Applications

Read More  

MADRAS (2020)

ADVANCED MATERIALS AND PROCESSING IN ORGANIC ELECTRONICS

Read More